Biomarkers for Diabetic Retinopathy Progression
Research type
Research Study
Full title
Retrospective Cohort Study of Imaging and Clinical Biomarkers for Predicting Disease Progression in Retinal Vascular Diseases
IRAS ID
372934
Contact name
Tariq Aslam
Contact email
Sponsor organisation
University of Manchester
Duration of Study in the UK
1 years, 0 months, 0 days
Research summary
Retinal vascular diseases, including diabetic retinopathy and retinal vein
occlusions, are major causes of preventable sight loss in working-age adults.
Some patients progress to more severe disease, which carries higher risk of vision
loss. Currently, we cannot reliably predict which patients will progress.This research uses advanced retinal imaging (ultra-widefield OCT angiography) and
clinical biomarkers to identify factors that predict disease progression in patients
with retinal vascular diseases. We will examine routine clinical imaging scans and
associated clinical data (such as blood sugar control, blood pressure, visual acuity,
and treatment history) that have already been collected as part of standard eye care
at Manchester Royal Eye Hospital.The study lasts for one year and is retrospective - we analyze existing data - but patients will be actively
approached and asked for consent to use their data for research. Participation is
voluntary and patients may decline or withdraw without affecting their clinical care.There is no new imaging or clinical procedures. All data used has been obtained during
routine clinical care. We will work with pseudonymized (coded) data to protect patient
privacy. Identifiable information will be accessed only by authorized NHS staff for
data extraction and linking.By identifying which imaging features and clinical markers predict progression in
retinal vascular diseases, we can help ophthalmologists identify high-risk patients
earlier and provide more personalized care.The study will improve our understanding of how retinal vascular diseases progress
and may lead to better surveillance strategies and treatment decisions for patients
with these serious eye conditions.REC name
East Midlands - Nottingham 1 Research Ethics Committee
REC reference
26/EM/0172
Date of REC Opinion
4 Aug 2026
REC opinion
Favourable Opinion